[To the question of the possibility of using selective chromotherapy for allergic diseases in children]

I V Pogonchenkova1, N A Lyan1,2, M A Khan2,3

  • 1Moscow Center for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine, Moscow, Russia.

Insights

Selective chromotherapy using green light improved bronchial asthma in 92% of children. Blue light therapy was effective in 80% of children with atopic dermatitis, reducing symptoms and improving quality of life.

Area of Science:

  • Pediatrics
  • Allergology
  • Complementary and Alternative Medicine

Background:

  • Allergic diseases are prevalent in childhood.
  • Non-drug therapies are crucial for managing childhood allergies, reducing medication reliance and prolonging remission.
  • Selective chromotherapy offers a non-invasive approach to complement standard allergy treatments.

Purpose of the Study:

  • To scientifically validate the use of selective chromotherapy in pediatric patients diagnosed with bronchial asthma (BA) and atopic dermatitis (AD).

Main Methods:

  • A study involving 120 children with BA and AD.
  • Bronchial asthma patients received 10 days of green light therapy on active zones; controls received no physiotherapy.
  • Atopic dermatitis patients received blue light therapy on affected areas; controls used only moisturizers.

Main Results:

  • Green light therapy demonstrated 92% efficacy in children with bronchial asthma.
  • Blue light therapy showed 80% effectiveness in children with atopic dermatitis.
  • Developed indications for selective chromotherapy based on disease severity and patient status.

Conclusions:

  • Green light therapy positively impacts the clinical course of pediatric BA, improving bronchial patency and psychoemotional status.
  • Blue light therapy for pediatric AD reduces symptom severity, itching, and skin lesion area, enhancing sleep quality.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Allergic Reactions02:06

Allergic Reactions

Overview
31.6K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.3K
Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
3.0K